Código QR

The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review

Abstract Background The adoption of immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) and/or local therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has been utilized as neoadjuvant or conversion therapy for...

Descripción completa

Guardado en:
Autores principales: Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2025-12-01
Colección:BMC Cancer
Materias:
Immune checkpoint inhibitors
Conversion therapy
Neoadjuvant therapy
Hepatocellular carcinoma
Liver resection
Acceso en línea:https://doi.org/10.1186/s12885-025-15449-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares